Haleon PLC HLN

Morningstar Rating
GBX328.30 +0.50 (0.15%)
View Full Chart

Company Report

Haleon Sees Volume Recovery From North America, and Margins Continue to Improve

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple nonstrategic brands, slimming down its manufacturing footprint, and dialing back the number of warehouses and distribution centers. We appreciate the firm's efforts to optimize its business and believe it is well established to enjoy long-term industry trends, including an aging population, premiumization of consumer healthcare products, and growing emerging markets, that should fuel its top line.

Price vs Fair Value

HLN is trading within a range we consider fairly valued.
Price
GBX327.80
Fair Value
LOCK|#d
Uncertainty
LOCK|%^Fn
1-Star Price
LOCK|g.m$
5-Star Price
LOCK|@.<
Economic Moat
LOCK|C@L
Capital Allocation
LOCK|^&Qt@ft

Bulls Say, Bears Say

Bulls

We expect Haleon, with financial and operational independence, to bolster its portfolio through product innovation and tuck-in acquisitions and expand the strong foothold it has in the consumer self-care industry.

Bears

Personalization of health paves the way for smaller niche players to carve out their shares of the market with bespoke offerings, and Haleon will have a tough time fighting for these areas given the difficulty of catering to these consumers with their megabrands.

News

Trading Information

Previous Close Price
GBX327.80
Day Range
GBX324.80–332.60
52-Week Range
GBX317.80–416.10
Bid/Ask
GBX320.00 / GBX390.00
Shares Outstanding
8.80B
Market Cap
GBX2.89T
Volume/Avg
27M / 24M

Key Statistics

Price/Earnings (Normalized)
18.32
Price/Sales
2.63
Dividend Yield (Trailing)
2.22%
Dividend Yield (Forward)
2.22%
Dividend Payment Schedule
May, Sep
Total Yield
4.78%

Company Profile

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
24,524

Competitors

Valuation

Metric
HLN
RKT
PG
Price/Earnings (Normalized)
18.3218.0621.21
Price/Book Value
1.765.506.20
Price/Sales
2.632.344.01
Price/Cash Flow
13.5813.1218.17
Price/Earnings
HLN
RKT
PG

Financial Strength

Metric
HLN
RKT
PG
Quick Ratio
0.510.380.41
Current Ratio
0.690.590.68
Interest Coverage
7.458.8423.74
Quick Ratio
HLN
RKT
PG

Profitability

Metric
HLN
RKT
PG
Return on Assets (Normalized)
5.49%9.05%13.14%
Return on Equity (Normalized)
10.94%33.99%31.34%
Return on Invested Capital (Normalized)
8.05%15.92%19.01%
Return on Assets
HLN
RKT
PG

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|TgL^YxD$LOCK|<?kG&$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|x&n?&zyLOCK|Ln>?$46B
Haleon PLC ADR
HLN
LOCK|<G<&?%$LOCK|^!$38B
Zoetis Inc Class A
ZTS
LOCK|BT%T%@cLOCK|ZP$29B
Viatris Inc
VTRS
LOCK|Q@c<@?BLOCK|d@$20B
Elanco Animal Health Inc
ELAN
LOCK|Bh$LOCK|ns@$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|@JR&q$LOCK|b$J$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|?g$S%fLOCK|>#$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|hb?Y#j%LOCK|g?VSj$2B
Perrigo Co PLC
PRGO
LOCK|FjbPnNLOCK|gl$2B

Sponsor Center